UK Business Park





The information on this page comes from the UK Activity Report.
One-month trial now available for £20!


Phytopharm

Phytopharm is to raise £25m in a share placing to fund the commercial development of its plant-based pharmaceutical products. 07-Dec-2009

Phytopharm is to shed 15 of the 40 jobs at its biotechnology research business in Godmanchester. 19-Feb-2009

Phytopharm has raised £8.6m in a share placing to fund the commercial development of pharmaceuticals from medicinal plants. 26-Mar-2008

Phytopharm has raised £1.7m in a share placing to strengthen its balance sheet and fund the commercial development of pharmaceutical products. 05-Mar-2007

Phytopharm is to raise £24m in a share placing to fund the development of new plant-based medicines. 03-Feb-2005

Phytopharm has raised £6.5m in a share placing, in order to strengthen its balance sheet and increase production of plant-based pharmaceuticals. 26-Feb-2004

Phytopharm has raised £11m in a share placing to fund the development of a new treatment for Alzheimer's disease. 30-Nov-2000

Phytopharm is raising £4.3m in a share placing in order to fund the development of three new plant-based biotechnology products. 01-Dec-1999

Phytopharm is raising £2.2m in a share placing in order to fund the development of plant-based pharmaceuticals. 17-Nov-1998

Phytopharm is linking up with Heska of the US to develop a number of its plant-based medicines. 05-Nov-1998

Phytopharm has awarded marketing rights for its P57 plant-based appetite suppressing compound to Pfizer of the US, and will receive up to £19m in licensing fees and milestone payments. 25-Aug-1998

Phytopharm is in negotiations to licence its drugs to a number of multinational companies, and interest is said to focus on its P45 treatment for baldness and its P54 treatment for osteoarthritis. 18-Jun-1998

Phytopharm is to begin human trials for a curcuma-based anti-arthritis drug, and hopes to win full UK approval by 2002. 07-May-1998

Nomura International has bought a 17.1% stake in Phytopharm, the biotechnology group, from Ethical Holdings. 13-Dec-1997

Phytopharm has been given US FDA approval to start clinical trials of an eczema cream made from plants, which could result in the development of many traditional herbal remedies even though explanations cannot be given as to how they work. 08-Dec-1997

Phytopharm has won an EU grant of £500,000 to develop a biotechnology-based treatment for osteoarthritis and Crohn's disease using the spice turmeric. 16-May-1997

Phytopharm, the plant-based medicines concern, is to float in London next month to raise over £12m. 16-Mar-1996



The information on this page comes from the UK Activity Report.
One-month trial now available for £20!












Copyright UK Business Park 1995-2009